References
- Sabetta J R, Andriole V T. Cryptococcal infection of the central nervous system. Med Clin North Am 1985; 69: 333–344
- Eng R HK, Bishburg E, Smith S M, Kapila R. Cryptococcal infections in patients with the acquired immune deficiency syndrome. Am J Med 1986; 81: 19–23
- Theunissen A WJ, Zanen H C. Dertig patienten met een “verborgen” ziekte: Cryptococcen-meningitis. Ned Tijdschr Geneeskd 1987; 131: 1123–1128, (Abstract in English.)
- Biggar R J. The AIDS problem in Africa. Lancet 1986; 1: 79–83
- Piot P, Taelman H, Minlangu K B, Mbendi N, Ndangi K, Kalambayi K, Bridts C, Quin T C, Feinsod F M, Wobin O, Mazebo P, Stevens W, Mitchell S, McCormick J B. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984; 2: 65–69
- Bennett J E, Dismukes W E, Duma R J, Medoff G, Sande M A, Gallis H, Leonard J, Fields B T, Bradshaw M, Haywood H, McGee Z A, Gate T R, Cobbs C G, Warner J F, Ailing D W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126–131
- Perfect J R, Durack D T. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother 1985; 16: 81–86
- Perfect J R, Savani D V, Durack D T. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob Agents Chemother 1986; 29: 579–583
- Polsky B, Depman M R, Gold J WM, Galicich J H, Armstrong D. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med 1986; 81: 24–28
- UK-49,858. Investigators reference manual. Pfizer Central Research, SandwichKent, England.
- Mattie H, Hoogeterp J J, Hermans J. The relation between plasma and tissue concentrations of antibiotics. Description of a method. J Pharmacokinet Biopharm 1987; 15: 191–202
- Graybill J R, Levine H B. Successful treatment of cryptococcal meningitis with intraventricular miconazole. Arch Intern Med 1978; 138: 814–816
- Perfect J R, Durack D T, Hamilton J D, Gallis H A. Failure of ketoconazole in cryptococcal meningitis. JAMA 1982; 247: 3349–3351
- Fibbe W E, Van der Meer J WM, Thompson J, Mouton R P. CSF concentrations of ketoconazole. Antimicrob Agents Chemother 1980; 6: 681
- Perfect J R, Durack D T. Treatment of experimental cryptococcal meningitis with amphotericin B,5-fluorocytosine, and ketoconazole. J Infect Dis 1982; 146: 429–435
- Craven P C, Graybill J R. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. J Infect Dis 1984; 149: 584–589
- Diamond R D, Bennett J E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80: 176–181
- Perfect J R, Durack D T. Effects of cyclosporine in experimental cryptococcal meningitis. Infect Immun 1985; 50: 22–26
- Dismukes W E, Bennett J E, Drutz D J, Graybill J R, Remington J S, Stevens D A. Criteria for evaluation of therapeutic response to antifungal drugs. Rev Infect Dis 1980; 2: 535–545